China has for the first time approved a Covid-19 vaccine based on mRNA technology, greenlighting a homegrown shot months after the ruling Communist Party eliminated its strict pandemic restrictions in December.

The shot, developed by CSPC Pharmaceutical Group Ltd., based in the northern Chinese city of Shijiazhuang, was approved for emergency use by China’s health regulator, according to a statement from the company on Wednesday.

China has long refused to use the foreign-made mRNA shots that were crucial in easing the pandemic in many parts of the world. It chose instead to promote its own pharmaceutical firms, first in rolling out a more traditional but less effective Covid vaccine, and later, in the pursuit of a homegrown mRNA, or messenger RNA, vaccine.

Nicole Hong and Alexandra Stevenson

Source link

You May Also Like

EMIR Refit: Starting 2023 with assurance | Insights | Bloomberg Professional Services

This article was written by Alexis Wiazmitinoff, Product Manager for EMEA Regulatory…

Tom Ford bows out from eponymous brand after multibillion takeover deal

US fashion designer Tom Ford is retiring from the eponymous brand he…

Retail Sales Fell in November, Despite Black Friday

Retail sales fell in November, with spending on even traditionally popular holiday…

What Is EBITDA? Here’s Everything To Know | Entrepreneur

EBITDA, an acronym for earnings before interest, taxes, depreciation and amortization, is…